Pharmacovigilance and Drug Safety Software Market By Functionality (Adverse Event Reporting Software, Issue Tracking Software), By Mode of Delivery (On-premise, On-demand), By End User (Pharma & Biotech Companies, Contract Research Organizations (CROS)), Global Analysis to 2023
Published Date: July - 2024 | Publisher: MRA | No of Pages: 240 | Industry: Media and IT | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationPharmacovigilance and Drug Safety Software Market By Functionality (Adverse Event Reporting Software, Issue Tracking Software), By Mode of Delivery (On-premise, On-demand), By End User (Pharma & Biotech Companies, Contract Research Organizations (CROS)), Global Analysis to 2023
Pharmacovigilance and Drug Safety Software Market Size And Forecast
According to the new report titled " Pharmacovigilance and Drug Safety Software Market By Functionality (Adverse Event Reporting Software, Issue Tracking Software), By Mode of Delivery (On-premise, On-demand), By End User (Pharma & Biotech Companies, Contract Research Organizations (CROS)), Global Analysis to 2023"
The valuation of the Pharmacovigilance and Drug Safety Software market was $7.23 Billion in 2023 and is projected to reach $18.03 Billion by 2032, at a CAGR of 11.05% from 2021 to 2032.
The market for software that helps track and ensure the safety of medications has been growing steadily. By 2023, it was worth about $7.23 billion, and experts predict that it will continue to grow by about 11% each year for the foreseeable future. This software helps drug companies, regulators, and healthcare providers keep an eye on how well drugs and other medical products work and how safe they are throughout their lifetime. The pharmaceutical industry is getting more complex, with new drugs like biologics, gene therapies, and other cutting-edge treatments being developed. These new treatments often have unique safety concerns and potential risks. Plus, there's always the worry about how drugs interact with each other, how they're used off-label, and what their long-term effects might be. All of this makes it clear that we need strong pharmacovigilance systems that can keep an eye on and evaluate the safety of drugs in a comprehensive way.
Imagine a world where powerful tools like data analytics, AI, and machine learning are helping us keep an eye on the safety of medicines. These tools can automatically spot any potential problems, predict risks, and even tell us how big a risk something is. Pharmacovigilance software uses these clever tricks to make sense of the mountains of data about medicine safety. It can spot any new issues that might be popping up, and it can even point out the ones that need to be looked into right away. The demand for this software is skyrocketing because AI can make pharmacovigilance so much better. It can help us do things faster and smarter. But it's not just about speed. With clinical trials and medicine supply chains happening all over the world, keeping track of medicine safety is getting more complicated. Different countries have different rules, so the software needs to be able to handle all of them. It also needs to make it easy for everyone to share data and work together. So, pharmaceutical companies are looking for software that speaks different languages, follows regional rules, and can grow as they need it to. This demand is fueling the growth of advanced pharmacovigilance solutions that can help us ensure the safety of medicines for everyone.
Adverse Event Reporting Software held the largest share in the Pharmacovigilance and Drug Safety Software market
Imagine you're a healthcare provider who wants to keep your patients safe and manage any problems that pop up. That's where Adverse Event Reporting Software (AERS) comes in. It's like a special tool that helps you collect and keep track of any issues that patients might experience with their medications or treatments. Think of it this waywhen you see a patient who's having a reaction to a drug or medical device, AERS makes it easy for you to write down what's happening, when it happened, and how severe it is. This helps you and your team figure out what caused the problem and what you can do to prevent it from happening to others. It's like being a detective for patient safety! AERS helps you uncover any risks or problems with healthcare products so you can investigate and figure out how to fix them. This makes it less likely that other patients will have the same issues, and everyone can get the best care possible. As the world gets more connected, AERS is becoming even more important. Now, hospitals and healthcare teams often work together across different countries and regions. AERS can be set up to match different rules and regulations, so healthcare providers can keep track of problems no matter where they are. This helps make sure that everyone gets the same high-quality care, no matter where they live.
North America headed the Pharmacovigilance and Drug Safety Software market in 2023
The pharmaceutical industry in North America is always trying to find new ways to treat diseases and develop drugs that are tailored to individual patients. These new treatments can have unique side effects that require special monitoring. That's where pharmacovigilance software comes in. This software has powerful tools that can analyze large amounts of information and identify any potential safety concerns. It also helps companies keep track of how their drugs are doing in the real world so they can make sure they're safe and effective. Pharmaceutical companies in North America are also using technology to make their pharmacovigilance processes more efficient and accurate. For example, they're using software that can automate tasks, analyze data quickly, and even detect problems that might not be obvious to the naked eye. As the industry continues to globalize, pharmaceutical companies need to be able to manage data from all over the world. That's why pharmacovigilance software that can adapt to different languages and regulations is so important. Key Players in the Pharmacovigilance Software Market [List of key players]
profiled in the report AB Cube, ArisGlobal LLC, Ennov USA, Extedo GmbH, Online Business Applications, Inc., Oracle Corporation, Sarjen Systems Pvt. Ltd., Sparta Systems, Inc., United Biosource Corporation etc
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| STUDY PERIOD |
2021-2031 |
| BASE YEAR |
2024 |
| FORECAST PERIOD |
2024-2031 |
| HISTORICAL PERIOD |
2021-2023 |
| UNIT |
Value (USD Billion) |
| KEY COMPANIES PROFILED |
Oracle Corporation, IQVIA, ArisGlobal LLC, SAS Institute Inc., Sparta Systems, Inc., Online Business Applications Inc., Ennov, Sarjen Systems Pvt. Ltd., EXTEDO, GmbH, Linical Accelovance, OpenText Corporation, Umbra Global LLC, AB Cube, PharmaLex GmbH, Veeva Systems Inc., Saranas Data Systems, Inc., DLRC LTD, Virtify, Inc.. |
| SEGMENTS COVERED |
By Functionality, By Deployment Mode, By End-User, By Geography |
| CUSTOMIZATION SCOPE |
Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Players
- Oracle Corporation
- IQVIA
- ArisGlobal LLC
- SAS Institute Inc.
- Sparta Systems
- Inc.
- Online Business Applications Inc.
- Ennov
- Sarjen Systems Pvt. Ltd.
- EXTEDO
- GmbH
- Linical Accelovance
- OpenText Corporation
- Umbra Global LLC
- AB Cube
- PharmaLex GmbH
- Veeva Systems Inc.
- Saranas Data Systems
- Inc.
- DLRC LTD
- Virtify
- Inc.
Global Pharmacovigilance and Drug Safety Software MarketSegmentation Analysis
The Global Pharmacovigilance and Drug Safety Software Market is segmented based on Functionality, Deployment Mode, End-User, and Geography.
Pharmacovigilance and Drug Safety Software Market, By Functionality
- Case Data Collection and Management
- Adverse Event Reporting and Analysis
- Signal Detection and Other Safety Risk Assessment
The Pharmacovigilance and Drug Safety Software market is like a puzzle made up of different pieces, each with its own job. The biggest piece is Case data collection and management. This part is all about gathering and organizing reports of any problems or side effects that patients have with their medications. Think of it like a giant filing cabinet where all these reports are stored and kept track of. Then there's Adverse event reporting and analysis. This piece is responsible for figuring out what's causing the problems and if they're serious. It's like a detective trying to solve a mystery. Signal detection is another important piece. It's like a lookout that watches for any patterns or trends in the reports. If it spots anything suspicious, it sounds the alarm. Finally, there's other safety risk assessment. This piece looks at all the data and figures out how big the risk is from any potential problems or side effects. All these pieces work together to make sure that medications are safe for us to use. The Case data collection and management piece is especially important because it's the foundation for everything else. Without it, we wouldn't have the information we need to investigate problems, find patterns, and assess risks. And that's why it's the biggest piece of the puzzle.
Pharmacovigilance and Drug Safety Software Market, By Deployment Mode
- On-Premise
- On-Demand
The Pharmacovigilance and Drug Safety Software market is like a pie, and it's been sliced into two big piecesone for on-premise software and one for on-demand software. Right now, the biggest slice belongs to on-demand software. Why is on-demand software so popular? Because it's like a buffet for businesses. It's cost-friendly, easy to scale up or down, and accessible from anywhere. That means companies can streamline their pharmacovigilance operations, work together better, and stay in line with the rules. And here's another slice of the piecloud-based solutions. These are like the superheroes of the software world because they're scalable, cost-effective, easy to set up, accessible from anywhere, secure, and compliant. As more businesses go digital and move to the cloud, cloud-based pharmacovigilance solutions are going to become even more popular.
Pharmacovigilance and Drug Safety Software Market, By End-User
- Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
- CROs/BPOs or PV service providers
- Others
The world of pharmacovigilance and drug safety software is divided into three main groupshealthcare companies, CROs/BPOs, and others. Healthcare companies are the big players, accounting for the lion's share of the market. These include pharma giants, biotech startups, medical device makers, and even contract research organizations (CROs). They all have teams whose job it is to keep a close eye on the safety of their products from start to finish. To do this, they need powerful software that can help them collect, sort through, and report any problems that come up with their products. They also need to make sure they're following all the rules and regulations so that they can keep their patients safe. The rise of CROs, BPOs, and other PV service providers shows that more and more healthcare companies are turning to outside experts for help with pharmacovigilance. These companies have the skills and tools to handle the complex and ever-changing world of drug safety, so healthcare companies can focus on what they do bestdeveloping new and better treatments for patients.
Pharmacovigilance and Drug Safety Software Market, By Geography
- North America
- Europe
- Asia Pacific
- Rest of the World
Across the globe, the market for software that helps track and manage drug safety and effectiveness is divided into different regions. Among these, North America has the biggest share of this market. North America's grip on this market stems from its strict rules for drug safety, its cutting-edge healthcare system, and its well-established pharmaceutical industry. The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have put in place strong frameworks for monitoring drug safety, which has fueled the demand for advanced software solutions. Meanwhile, the Asia Pacific region is seeing rapid growth in this market. That's because countries like China, India, and Japan are spending more on healthcare, which includes improving drug safety practices. These countries also have thriving pharmaceutical industries. As the regulatory landscape in the region evolves, technology advances, and awareness about medication safety grows, the Asia Pacific region is becoming increasingly important in the global market.
Reasons to Purchase this Report
Imagine you're exploring a bustling market, eager to uncover its secrets. We're here as your guide, providing a comprehensive analysis that will help you make informed decisions. First, we'll divide the market into different groups based on factors like income, lifestyle, and preferences. Then, we'll give you detailed info on the size and value of each segment. Next, we'll show you which region and segment are likely to grow the fastest, so you know where to focus your attention. We'll also analyze different geographic areas to understand how people in each region are using the product or service, and what's influencing their choices. To stay up-to-date on the latest trends, we'll keep you updated on new product launches, partnerships, and acquisitions by major players in the market. We'll also provide in-depth profiles of these companies, complete with overviews, insights, product comparisons, and SWOT analyses. We'll also explore the industry's future prospects, identifying growth drivers, opportunities, and challenges in both developed and emerging markets. To give you a comprehensive view, we'll use Porter's Five Forces analysis and Value Chain analysis to examine the market dynamics. Finally, we'll provide you with ongoing support for six months after your purchase, so you can stay on top of the latest market trends and make the most of your investment.
Table of Content
1. Introduction
• Market Definition
• Market Segmentation
• Research Methodology
2. Executive Summary
• Key Findings
• Market Overview
• Market Highlights
3. Market Overview
• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis
4. Pharmacovigilance And Drug Safety Software Market, By Type of Software
• Adverse Event Reporting Software
• Signal Detection and Management Software
• Risk Management Software
• Compliance Management Software
• Signal Intelligence Software
• Electronic Data Capture (EDC) Software
5. Pharmacovigilance And Drug Safety Software Market, By Delivery Mode
• On-Premises Solutions
• Cloud-Based Solutions
6. Pharmacovigilance And Drug Safety Software Market, By End-User
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Medical Device Companies
• Regulatory Authorities and Health Agencies
7. Regional Analysis
• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE
8. Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market
9. Competitive Landscape
• Key Players
• Market Share Analysis
10. Company Profiles
• Ennov Solutions Inc.
• Extedo GmbH
• United BioSource Corporation
• Ab Cube
• ArisGlobal
• Oracle Corporation
• Sarjen Systems Pvt Ltd
• Sparta Systems Inc.
11. Market Outlook and Opportunities
• Emerging Technologies
• Future Market Trends
• Investment Opportunities
12. Appendix
• List of Abbreviations
• Sources and References
Key Players
- Oracle Corporation
- IQVIA
- ArisGlobal LLC
- SAS Institute Inc.
- Sparta Systems
- Inc.
- Online Business Applications Inc.
- Ennov
- Sarjen Systems Pvt. Ltd.
- EXTEDO
- GmbH
- Linical Accelovance
- OpenText Corporation
- Umbra Global LLC
- AB Cube
- PharmaLex GmbH
- Veeva Systems Inc.
- Saranas Data Systems
- Inc.
- DLRC LTD
- Virtify
- Inc.
Related Reports
- Blockchain Identity Management Market Size - By Offering (Software, Service), By Provider Type (Application Provider, Mi...
- PayTV Market - By Technology (Cable TV, Satellite TV, Internet Protocol TV), By Subscription Type (Postpaid, Prepaid), ...
- Generative AI in Logistics Market - By Type (Variational Autoencoder (VAE), Generative Adversarial Networks (GANs), Recu...
- AI in Industrial Machinery Market - By Component (Hardware, Software, Services), By Technology (Machine Learning, Comput...
- Explainable AI Market Size - By Component (Solution, Service), By Software Service (Standalone Software, Integrated Soft...
- Casual AI Market Size - By Offering (Platform [ Deployment {Cloud, On-premises}], Services [Consulting, Deployment & Int...
Table of Content
Will be Available in the sample /Final Report. Please ask our sales Team.
List Tables Figures
Will be Available in the sample /Final Report. Please ask our sales Team.
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy